Zhengye Biotechnology Holding (ZYBT) Retained Earnings (2023 - 2025)

Zhengye Biotechnology Holding has reported Retained Earnings over the past 3 years, most recently at -$271551.7 for Q4 2025.

  • Quarterly Retained Earnings fell 65119.42% to -$271551.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$271551.7 through Dec 2025, down 65119.42% year-over-year, with the annual reading at -$275000.0 for FY2025, 104.17% down from the prior year.
  • Retained Earnings was -$271551.7 for Q4 2025 at Zhengye Biotechnology Holding, down from -$135000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $5.3 million in Q4 2023 and troughed at -$271551.7 in Q4 2025.
  • The 3-year median for Retained Earnings is -$67291.2 (2024), against an average of $1.2 million.
  • Year-over-year, Retained Earnings crashed 99.99% in 2024 and then tumbled 65119.42% in 2025.
  • A 3-year view of Retained Earnings shows it stood at $5.3 million in 2023, then crashed by 99.99% to $417.65 in 2024, then tumbled by 65119.42% to -$271551.7 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Retained Earnings are -$271551.7 (Q4 2025), -$135000.0 (Q2 2025), and $417.65 (Q4 2024).